Literature DB >> 17021272

A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss.

D Santini1, B Vincenzi2, M Caraglia3, G Tonini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17021272     DOI： 10.1093/annonc/mdl298

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case.

Authors:  S Deshayes; N Martin Silva; J Cogez; A Baldolli; S Fedrizzi; B Bienvenu; A Aouba
Journal:  Osteoporos Int       Date:  2016-03-15       Impact factor: 4.507

2.  Acute effects of intravenous administration of pamidronate in patients with osteoporosis.

Authors:  Mie Jin Lim; Seong Ryul Kwon; Shin-Goo Park; Won Park
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

3.  Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid.

Authors:  Marco Mozzati; Germana Martinasso; Marina Maggiora; Matteo Scoletta; Marta Zambelli; Stefano Carossa; Manuela Oraldi; Giuliana Muzio; Rosa Angela Canuto
Journal:  Clin Oral Investig       Date:  2012-08-03       Impact factor: 3.573
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.